Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Mutivariate Analyses for Part Patients (n = 39)

From: TRPM7 promotes the epithelial–mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling

Characteristics

DFS

OS

 

HR(95%CI)

P-value

HR (95%CI)

P-value

Level of E-cadherin

expression (high vs. low)

1.423

(0.634–3.192)

0.0455

1.241

(0.553–2.78)

0.0452

Level of Vimentin

expression (high vs. low)

1.974(1.147–5.053)

0.0434

2.161(1.178–5.334)

0.0317

Level of Twist

expression (high vs. low)

2.350(1.316–5.981)

0.0164

2.248

(1.175–5.327)

0.0227

  1. HR hazard ratio, CI confidence interval, DFS disease-free survival, OS overall survival
  2. Higher E-cadherin, Vimentin and Twist expression were independently associated with the poor prognosis of patients with ovarian cancer